Can smarter screening save premature Babies' sight?

NCT ID NCT06729333

Completed Knowledge-focused Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study is looking at thousands of premature and low-birth-weight babies in China to understand how common retinopathy of prematurity (ROP) is today. ROP is an eye condition that can lead to blindness if not caught early. The researchers want to find out the best time and criteria for screening, so that babies who need treatment are identified sooner, while avoiding unnecessary tests for those at lower risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to more accurate and cost-effective screening guidelines for retinopathy of prematurity in China, potentially preventing blindness in preterm infants.
What could go wrong: The study is observational and does not test a treatment. Its findings depend on the participating hospitals and may not apply to all regions or healthcare settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW BIRTHWEIGHT INFANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth retinopathy of prematurity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOW BIRTHWEIGHT INFANT PREMATURE BIRTH OF NEWBORN RETINOPATHY OF PREMATURITY (ROP)

Contacts and locations

Locations

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, 200092, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.